Research across Urologic Neoplasms
Related studies from across the Urologic Neoplasms family.
Belzutifan and Lenvatinib Combination Improves Progression Free Survival in Advanced Renal Cell Carcinoma
Trial shows new drug combo slows advanced kidney cancer growth
A Phase 3 trial demonstrates that the belzutifan-lenvatinib combination significantly extends progression-free survival in patients with adv…
A new drug combination helped slow the growth of advanced kidney cancer in patients who did not respond to earlier treatments.
First-line immune checkpoint inhibitors plus anti-angiogenic therapy improve progression-free survival and response rates in advanced RCC
Combination Therapy Shows Better Outcomes for Advanced Renal Cell Carcinoma
This meta-analysis of 4,977 patients found that first-line immune checkpoint inhibitors combined with anti-angiogenic therapy significantly …
A new combination of immune checkpoint inhibitors and anti-angiogenic therapy shows better survival rates than standard treatment for advanc…
cGAS-STING pathway activation drives inflammation, fibrosis, and podocyte injury in various kidney diseases
New research identifies a key pathway in kidney disease progression
This systematic review synthesizes preclinical data on the cGAS-STING signaling pathway's role in acute kidney injury, chronic kidney diseas…
A specific signaling pathway called cGAS-STING acts as a central hub, linking inflammation and metabolism to several types of serious kidney…
Comparative Efficacy of Robot Assisted Radical Nephrectomy and Open Surgery for IVC Thrombus
Robot assisted surgery shows fewer complications for certain kidney cancers
Meta-analysis indicates robot-assisted radical nephrectomy reduces blood loss, transfusion needs, and major complications in patients with r…
Robotic surgery may reduce blood loss and hospital stays for patients with specific types of kidney cancer involving the inferior vena cava.
FH-deficient renal cell carcinoma case shows rapid bone metastasis despite adjuvant therapy
Rare Kidney Cancer Case Shows Aggressive Spread Despite Treatment
This case report and literature review describes a 42-year-old woman with FH-deficient renal cell carcinoma and uterine leiomyomas, treated …
A rare kidney cancer in a 42-year-old woman spread quickly despite surgery and therapy, highlighting the need for early genetic testing.
Repeat ablation provides favorable outcomes for local recurrence after primary ablation in renal cell carcinoma
Local treatments show mixed results for recurring kidney cancer
This meta-analysis of 45 studies evaluates the efficacy of various local salvage therapies for patients with local recurrence of renal cell …
New data shows that while some local treatments work well for recurring kidney cancer, others face challenges with distant spread.
Disease-free survival shows strong correlation with overall survival in localized renal cell carcinoma
Disease free survival predicts long term outcomes for kidney cancer
This systematic review and trial-level meta-analysis of 9594 patients with localized renal cell carcinoma found a strong correlation between…
A large analysis shows that tracking how long patients stay cancer-free can help doctors predict overall survival in kidney cancer cases.
Comparative Efficacy of Immunotherapy Combinations in Advanced Renal Cell Carcinoma Management
New analysis compares immunotherapy combinations for advanced renal cell carcinoma
A network meta-analysis evaluates diverse immunotherapy combinations for advanced renal cell carcinoma, highlighting specific survival benef…
A large review of over 6,000 patients identifies specific immunotherapy combinations that may improve survival for those with advanced kidne…
Retroperitoneal approach in single-port robot-assisted partial nephrectomy may reduce blood loss and hospital stay
Retroperitoneal approach may offer benefits for kidney cancer surgery
This meta-analysis of 384 patients compares transperitoneal and retroperitoneal approaches for single-port robot-assisted partial nephrectom…
A new look at surgical methods suggests the retroperitoneal approach may reduce blood loss and hospital stays for patients with renal cancer…
Immune ecotypes may offer more refined patient stratification for ccRCC than current biomarkers
Immune Ecotypes May Guide Kidney Cancer Treatment
This mini review explores the use of immune ecotypes to identify treatment-responsive profiles in patients with advanced clear cell renal ce…
New review proposes four immune subtypes in kidney cancer that could explain why some patients respond to immunotherapy and others don't.
High PTTG1 expression correlates with poorer survival and advanced disease in various solid tumors
High levels of PTTG1 protein linked to worse cancer outcomes
This meta-analysis of 22 studies from 21 articles analyzed the prognostic value of PTTG1 expression across multiple solid tumors. High PTTG1…
A review of 22 studies shows that high levels of the PTTG1 protein are linked to shorter survival times in several types of solid tumors.
Spontaneous regression observed in a patient with cystic renal cell carcinoma
Kidney tumor shows spontaneous regression before surgery for diagnosis
A case report describes a patient with a cystic mass in the left kidney that exhibited spontaneous regression following an initial period of…
A rare case of kidney cancer showed unexpected shrinking before surgery, highlighting why early intervention is vital for diagnosing complex…